Loading
Exposure to clinical decision support system and education / Venous Thromboembolism / Deep Vein Thrombosis · Interventional Study
ClinicalTrials.gov · September 9, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a protocol registration for an ongoing stepped-wedge randomized trial evaluating whether an electronic medical record decision support tool combined with surgeon and patient education increases prescribing and adherence to extended VTE prophylaxis after cancer surgery. No efficacy or outcome data are reported in this registry record; results remain pending.
Interventional, Randomized, Parallel, Open label, Treatment purpose. Venous Thromboembolism, Pulmonary Embolism, Deep Vein Thrombosis, Cancer, Surgery; age from 18 Years. Intervention: Intervention. Compared with: Control — No Intervention. n = 30. 1 site: United States.
This is a protocol registration for an ongoing stepped-wedge randomized trial evaluating whether an electronic medical record decision support tool combined with surgeon and patient education increases prescribing and adherence to extended VTE prophylaxis after cancer surgery. No efficacy or outcome data are reported in this registry record; results remain pending.
This is a registry record with no results posted; efficacy, safety, and feasibility remain unknown.
The source did not state who this applies to in practice.
This is a registry record for an active interventional study with no results posted; it describes a planned stepped-wedge trial of a behavioral intervention (decision support and education) to improve VTE prophylaxis prescribing in cancer surgery, but enrollment and follow-up are incomplete.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06451003). This is a study registration, not published results. Lead sponsor: Medical University of South Carolina. Recruitment status: ACTIVE_NOT_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 30 participants (ESTIMATED). Conditions: Venous Thromboembolism, Pulmonary Embolism, Deep Vein Thrombosis, Cancer, Surgery. Interventions: BEHAVIORAL: Exposure to clinical decision support system and education. Primary outcome measures: Proportion of eligible patients receiving venous thromboembolism (VTE) prophylaxis prescription; surgeon cluster level analysis , Study duration: 30 months including pre-intervention (range: 6-18 months) and post-intervention (range: 9-21 months); Proportion of patients adherent to pharmacologic extended venous thromboembolism prophylaxis (ePpx) , 30 days postoperative. Brief summary: While blood clots after major cancer surgery are common and harmful to patients, the medications to decrease blood clot risk are seldom used after patients leave the hospital despite the recommendation of multiple professional medical societies. The reason why these medications are seldom prescribed is not well understood. The main questions this study aims to answer are: * Does surgeon education paired with an electronic medical record based decision support tool improve the guideline concordant prescription of pharmacologic venous thromboembolism after abdominopelvic cancer surgery? * Does dedicated patient education regarding blood clots at the time of hospital discharge after abdominopelvic cancer surgery improve understanding of the risk of venous thromboembolism and adherence to pharmacologic prophylaxis? The investigators will study these questions using a stepped-wedge randomized trial where groups of surgeons will use a tool integrated to the electronic medical record to educate them on the individualized patient risks of blood clots after major cancer surgery and inform them regarding guidelines for preventative medicines. Utilization of the medications before and after using the tool will be compared. Patients will be administered a questionnaire assessing their awareness of blood clots as a risk after cancer surgery. For those prescribed medications to reduce blood clot risk after leaving the hospital, the questionnaire will evaluate whether they took the medications as prescribed. Survey results will be evaluated before and after implementation of education on blood clot risk at the time of hospital discharge.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.